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ABSTRACT 
Here we detail a protocol for whole-mount immunostaining of mouse small intestinal 
villi that can be used to generate high-resolution, 3D images of all gut cell types 
including: blood and lymphatic vessels, neurons, smooth muscle cells, fibroblasts and 
immune cells. The Procedure describes perfusion, fixation, dissection, 
immunostaining, mounting, clearing, imaging and quantification, using intestinal 
vasculature as an example. Since intestinal epithelial cells prevent visualization with 
some antibodies, we also provide an optional protocol to remove these cells prior to 
fixation. In contrast to alternative current techniques, our protocol enables the entire 
villus to be visualized with increased spatial resolution of cell location, morphology 
and cell-cell interactions allowing for easy quantification of phenotypes. The 
technique, which takes 7 days from mouse dissection to microscopic examination, 
will be useful for researchers interested in most aspects of intestinal biology, 
including mucosal immunology, infection, nutrition, cancer biology and intestinal 
microbiota. 
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INTRODUCTION 
Vascular biology research relies heavily on analyzing vessel patterning and fine 
detailed vessel structures by whole-mount immunostaining. Common mouse models 
for studying blood and lymphatic vessel patterning are the postnatal pup retina and 
embryonic mesentery or skin, respectively1-4. These tissues can be flat-mounted for 
easy imaging and analyzed for vessel density, number of endothelial cells, and 
filopodia, among other parameters. These tissue models, used in combination with 
genetic tools for gene inactivation in blood or lymphatic endothelial cells, have led to 
significant advances in our understanding of sprouting (lymph)angiogenesis, vascular 
patterning and maturation5,6. The current challenge is to now understand the 
molecular mechanisms and principles that govern tissue-specific organization and 
function of adult vascular beds, which can be critical for our ability to treat a range of 
human diseases. Here we present a step-by-step protocol for 3D visualization of all 
stromal cells and structures, including blood and lymphatic vessels, in adult mouse 
small intestine.  
 
The adult mouse small intestine is a highly specialized organ, which harbors billions 
of bacteria and whose epithelial cells are constantly regenerating, so that the entire 
intestinal lining is replaced every few days. Its critical role in absorbing all dietary 
nutrients, as well as performing immunosurveillance of the intestinal microbiota, 
create a remarkable tissue microenvironment7. In particular, adult small intestinal 
blood capillaries and lymphatic vessels perform a distinct role, namely absorption and 
systemic distribution of all dietary nutrients, and display properties different from 
most adult vessels. Therefore, understanding molecular mechanisms underpinning the 
patterning and function of these vessels may lead to novel treatments for gut-related 
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diseases such as inflammatory bowel disease or colorectal cancer. Indeed, intestinal 
villus blood vessels are one of a handful of VEGF-dependent adult vascular beds8,9 
and their density is regulated by intestinal microbiota10,11 Dietary fat absorption is 
carried out by intestinal lymphatic vessels, also called lacteals,  and is uniquely 
promoted by lacteal contractions controlled by the autonomic nervous system12. In 
addition, our own and other recent work show that both intestinal villus blood and 
lymphatic vessels display hallmarks of (lymph)angiogenesis, such as filopodia and 
increased proliferation, and they slowly, but steadily regenerate, paralleling renewal 
of epithelial cells13,14. Furthermore, we found that lymphatic expression of the Notch 
ligand Dll4 is critical for maintaining such continuous lacteal regeneration. Therefore, 
by combining cell-specific genetic inactivation with advanced imaging techniques we 
were able to study the molecular mechanisms underlying lymphatic vessel 
specialization in the small intestine. Here we present in detail the protocol for 
intestinal whole-mount immunostaining.  
 
Development of the protocol 
One of the areas of interest in our laboratory has been the study of lymphatic 
collecting vessels with a focus on lymphatic valves3,15-17. The primary tool for 
analyzing phenotypes in transgenic mouse models for us and others is whole-mount 
immunostaining of the mouse mesentery, whose flat structure, similar to retina, 
allows high-resolution 3D analysis of blood and lymphatic vessels3,15-19. However, as 
we began to analyze the intestine, we realized that an equivalent detailed protocol was 
not available for small intestinal villi. Thin sectioning of paraffin or cryoblocks is 
often used for intestinal imaging and works very well to analyze the epithelium, 
however the complex structure of villi make it difficult to correctly image the 3D 
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stroma organization, especially blood and lymphatic vessels (Figure 1a). For example, 
accurately measuring lacteal length or blood vessel density can be difficult as villi 
sectioning prevents unambiguous identification of the lacteal tip and visualization of 
the cage-like blood vascular network. Imaging of thick cryosections is feasible and 
allows a more complete image of the villus stroma8,9 (Figure 1b), however, overall 3D 
structure and fine, but important, details of cell morphology, such as filopodia, are 
difficult to visualize and quantify. Furthermore, it is challenging to reliably analyze 
co-localization or interaction of different cell types in tissue sections. Therefore, we 
wanted to apply whole-mount immunostaining to allow high-resolution visualization 
of all cell types in small intestinal villi. 
 
Whole mount imaging of intestine by confocal microscopy has been previously used 
to study the submucosal20,21 and villus stroma10,22,23,  however a detailed step-by-step 
protocol has not been reported. Stappenbeck et al. examined blood vessels in small 
intestinal villi in whole-mount preparations10. Fu et al. incorporated perfusion fixation 
into whole-mount immunostaining of neuronal components of the small intestine and 
colon with visualization of blood vessel by dye intracardiac perfusion, focusing on the 
submucosal layer22. Furthermore, both Fu et al. and Appleton et al. performed tissue 
clearing of intestinal whole-mounts to increase fluorescent signal strength22,23. 
Recently, we used a new whole-mount immunostaining protocol to examine in detail 
both intestinal submucosal and villus stroma at high resolution13. Our protocol 
combines the tissue fixation procedure of Stappenbeck et al.10 and perfusion fixation, 
confocal microscopy and solvent-based clearing of Fu et al.22. However, we have also 
incorporated several major improvements into our approach (Table 1). For example, 
while solvent-based clearing allows many antibodies to be used effectively for 
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immunostaining of intestinal villi, some immunostainings are not easily visible in the 
presence of epithelial cells (even with solvent clearing); this can be due to a weak 
signal that is indistinguishable from epithelial cell background noise or due to specific 
high expression of the antigen to be stained in the epithelium (Supplementary Figure 
1). To overcome this limitation, we improved the protocol by developing a procedure 
for physically removing the epithelial cells so the stroma is rendered visible. A second 
key improvement was the development of a novel mounting strategy that allows villi 
to be imaged laterally (“side-view”) rather than transversally (“top down”; imaging 
with the tip of the villus pointing directly towards the microscope), which facilitates 
visualization of 3D structures without the need for image reconstruction. Importantly, 
likely due to the combination of cardiac perfusion fixation and specific tissue fixation 
conditions, we were able to visualize important structural features of angiogenic 
endothelial cells, such as filopodia, at high resolution13. Thus, the optimized protocol 
described here enables intestinal villi stroma to be visualized in more detail than 
previously possible using alternative approaches (Figure 2). 
 
Overview of the Procedure 
The Procedure begins with intracardiac paraformaldehyde (PFA) perfusion of mice. 
This is a critical step in the protocol as, in our hands, poor perfusion results in the 
rapid degradation of the tissue (presumably due to intestinal mucous, bacteria and/or 
digestion-related enzymes present in the gut) and an inability to stain and mount the 
intestine. After perfusion-fixation, the intestine is dissected and cleaned. Samples are 
then pinned to silicone plates before being re-fixed, extensively washed and 
immunostained using standard whole-mount immunostaining methods. After staining, 
strips of villi are carefully cut; strips should be 1-2 villi thick to ensure that villi will 
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be relatively transparent and easy to image. In order to obtain high-resolution images, 
the epithelial cells (which can prevent efficient stroma visualization) must be cleared 
before mounting onto slides for 3D imaging (Figure 3). We provide two different 
strategies for epithelial clearing. The first approach leaves epithelial cells in place 
(WM/EP(+)), which are rendered clear using a commercially available clearing 
solution; they can be either imaged by immunostaining or ignored if immunostaining 
is performed for stromal cells only. However, in our experience several antibodies 
cannot be used for whole-mount intestinal stroma immunostaining when epithelial 
cells are present, due to either high epithelial background staining or high specific 
epithelial staining that renders the stromal staining undetectable (Supplementary 
Table 1). Therefore we have also included an optional protocol to remove epithelial 
cells (WM/EP(-)), allowing imaging with a wider range of antibodies than in the 
presence of epithelial cells (Figure 3).  
 
We also provide an optional protocol for paraffin embedding tissue from the same 
samples used for whole-mount. In our hands, simultaneous harvest of samples for 
both whole-mount and paraffin embedding gives flexibility in analyzing e.g. 
endothelial cell proliferation as well as epithelial cell parameters. A common 
technique for preparing intestinal tissue is the “Swiss roll” where the intestine is cut 
open and flattened and then rolled and embedded in paraffin24. Although the Swiss 
roll technique for paraffin embedding of intestinal tissue is well known and 
established in many laboratories, we have included it in context of also performing 
intestinal whole-mount immunostaining (Supplementary Method 1). Note that 
removal of epithelial cells for WM/EP(-) is not efficient in the duodenum, therefore 
 9 
the upper duodenum half should be used for paraffin embedding and the lower part 
for WM/EP(+). 
 
Applications, advantages and limitations 
Here we show the utility of the protocol for immunostaining blood and lymphatic 
vessels to measure relative lacteal length and number of lacteal and villus blood 
vessel filopodia. However we have used the same method to visualize other cell types 
including neurons, smooth muscle cells, immune cells and fibroblasts (Figure 2a-d). 
Therefore, our protocol can be used to discover novel cell-cell interactions in small 
intestinal villi. In addition to cell immunostaining, the whole-mount technique also 
works well to stain extracellular matrix (ECM) proteins such as fibronectin, tenascin 
C and periostin (Figure 2f, g, Supplementary Table 1 and ref. 13).  
 
This protocol is best suited for analysis of the intestinal villus stroma. Epithelial cells 
are easily imaged using this protocol and stromal/epithelial interactions can be clearly 
visualized. Key advantages of the protocol include: perfusion fixation to ensure tissue 
quality for the duration of the procedure; epithelial clearing to enable the use of all 
antibodies validated for whole-mount immunostaining; and lateral mounting to avoid 
the need for image reconstruction. This mounting approach also facilitates analysis, as 
slides can be quickly examined by epifluorescencent microscopy to determine the 
quality of the immunostaining and detection of a phenotype. As a result of these 
improvements, this whole-mount protocol is superior to either paraffin or frozen 
sections for detecting fine structures and for analyzing stromal cell protein expression, 
patterning, location or co-localization.  
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However, if the goal of an experiment is to solely analyze epithelial cells, performing 
the traditional “Swiss roll” paraffin embedding technique should be sufficient, as well 
as less time consuming, for dissection, immunostaining and analysis. Furthermore, as 
PFA perfusion is a critical step in this protocol, combining whole-mount intestinal 
immunostaining with cell sorting is not feasible. Similarly, it is not possible to 
perform RNA or protein analysis from mice where PFA perfusion has been 
performed. Finally, since proper cleaning of the intestine requires vigorous flushing, 
our protocol will not be useful to visualize the intestinal mucus layer. 
 
 
Level of expertise needed to implement the protocol 
The techniques described in this protocol can be performed by anyone comfortable 
with handling mice, mouse dissection and confocal microscopy imaging. PFA 
perfusion and pinning of the intestine onto silicone plates are skills that are relatively 
straightforward after some practice. If preparing samples for paraffin embedding and 
whole-mount simultaneously, in our experience it is better to have two people: one 
experimenter handling the intestinal whole-mount, the other performing PFA 
perfusion and tissue preparation for paraffin embedding. In our hands, even with good 
PFA perfusion it is best to start the overnight intestine fixation as quickly as possible 
after dissection to avoid tissue degradation. If other tissues will also be collected at 
the same time it is better to add experimenters as necessary, so that all tissues are 
collected in a timely manner. 
 
 
Experimental design 
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Application to younger mice: The protocol described here is for adult mice, however 
we have also successfully used this protocol to analyze the intestine from P0 to 3-
week-old mouse pups. PFA perfusion fixation is essential for proper adult sample 
preparation and is well described by Gage et al.25 However, we do not perform PFA 
perfusion on pups, as it is technically challenging, and rather work rapidly to fix the 
intestine as quickly as possible.  
Conditional mutants: In our previous study13 we used Prox1-CreERT218 mice for 
conditional deletion in lymphatic endothelial cells and Pdgfβ-iCreERT2 mice26 for 
recombination in blood intestinal endothelial cells. Recombination in lymphatic 
endothelial cells has been reported for Pdgfβ-iCreERT2 mice in some tissues27, but 
we did not observe it in small intestinal lymphatic vessels. Tamoxifen was 
administered by a single or multiple intraperitoneal injection(s) to 8- to 12-week-old 
mice which were analyzed after 3 or 10 weeks13, however any treatment, mutant 
mouse line or other time points can be used.  
Choice of mice: The gut microbiota plays an important role in intestinal physiology, 
and studies of microbiota composition show large variations in cage effects between 
mice of different strains, sex and housing unit28. Therefore, if possible, when 
analyzing mutant mouse models, co-housed littermates of the same sex should be 
used for experiments. 
 
MATERIALS 
REAGENTS 
• Adult mice (8- to 12-weeks-old) 
Caution: All procedures involving animal experiments should follow approved 
institutional and governmental animal protocols and comply with the relevant 
guidelines and regulations of the local animal ethics committee. 
• Xylosol (Graeub, cat. no. 763.12) 
• Ketasol (Graeub, cat. no. 668.51) 
• 10X PBS (see Reagent Setup) 
• Picric acid (Sigma, cat. no. 197378) 
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Caution: Picric acid is a hazardous reagent; use a chemical fume hood and wear 
protective gloves and mask when you are preparing the fixative. Protect from light. 
• paraformaldehyde (PFA, Sigma, cat. no. 158127) 
Caution: PFA is a hazardous reagent; use a chemical fume hood and wear protective 
gloves and mask when you are preparing the fixative.  
• Ethylenediaminetetraacetic acid (EDTA, Applichem, cat. no. A3234)  
• NaH2PO4 (Sodium phosphate monobasic, Sigma, cat. no. S3139) 
• Na2H2PO4 (Sodium phosphate dibasic, Applichem, cat. no. A2943) 
• Sylgard® 184 Silicone elastomer kit (Dow Corning) 
• 87% Glycerol (Applichem, cat. no. A0970) 
• D(+)-sucrose (Applichem, cat. no. A2211) 
• NaN3 (Sodium azide, Applichem, cat. no. A1430) 
Caution: Sodium azide is a hazardous reagent; use a chemical fume hood and wear 
protective gloves and mask when you are preparing the fixative. 
• Donkey serum (Bio-Rad, cat. no. C065B) 
• Bovine serum albumin (Albumin fraction V, Applichem, cat. no. A1391) 
• Triton X-100 (Applichem, cat. no. A1388) 
• Primary Antibodies (rat anti-Pecam1, BD Pharmigen, cat. no. 557355; goat 
anti-Vegfr2, R&D, cat. no. AF644; rabbit anti-Lyve1, AngioBio, cat. no. 11-
034, rat anti-Ki67, BD Pharmigen, cat. no. 556003; rabbit anti-Erg, Abcam, 
cat. no. ab92513; goat anti-Prox1, R&D, cat. no. AF2727; goat anti-Vegfr3, 
R&D, cat. no. AF743, also see Supplementary Table 1) 
• Secondary Abs (donkey anti-rat IgG Alexa Fluor 488, cat. no. A-21208; 
donkey anti-goat IgG Alexa Fluor 555, cat. no. A-21432; donkey anti-rabbit 
IgG Alexa Fluor 647, cat. no. A-31573; donkey anti-rabbit IgG Alexa Fluor 
555, cat. no. A-31572; donkey anti-goat IgG Alexa Fluor 647, cat. no. A-
21447) 
Caution: Protect from light. 
• ProLong Gold antifade reagent with DAPI (Life Technologies, cat. no. 
P36931) 
• KCl (Potassium chloride, Applichem, cat. no. A1362) 
• NaCl (Sodium chloride, Sigma, cat. no. 71382) 
• KH2PO4 (Potassium hydrogen phosphate, Applichem cat. no. A1042) 
• 70% EtOH 
• FocusClear (CelExplorer Labs CO., cat. no. FC-101) 
• Xylene (ReactoLab, cat. no. 99814) 
• 100% EtOH 
• 90% (vol/vol) EtOH 
• High pH antigen retrieval buffer (Dako, EnVision FLEX Target Retrieval 
Solution, High pH, cat. no. K8004) 
• M.O.M. blocking reagent (Vector Laboratories, cat. no. BMK-2202) 
 
EQUIPMENT 
• Dissection microscope (e.g. Leica MZ16)  
• Perfusion apparatus (2 Infu-Surg Pressure Infusion bags, 1000 ml, Moog, cat. 
no. 4010) 
• Small Animal Butterfly Catheter Infusion Set (Harvard Apparatus, cat. no. 
725965) 
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• 3-way stopcock (e.g. CardioMed cat. no. 17-369C) 
• 20 ml syringe (Braun, cat. no. 4616200V) 
• 25G syringe needles (Braun, cat. no. 4657853) 
• Dissecting forceps (Aesculap, cat. no. BD210R) 
• Small forceps, 0.2 mm (Aesculap, cat. no. BD330R) 
• Very small forceps, 0.115 mm (Aesculap, cat. no. BD331R) 
• Artery scissors (Fine Science Tools, cat. no. 14080-11) 
• Very small scissors (Fine Science Tools, cat. no. 15000-00) 
• Scissors (Aesculap, cat. no. BC064R) 
• Microscope slides, 76x25 mm (Menzel-Gläser) 
• Secure-Seal spacer 20mm diameter, 0.12mm deep (Molecular Probes, cat. no. 
S24736) 
• Confocal microscope (e.g. Leica SP5) 
• Insect pins (Fine Science Tools, cat. no. 26002-20) 
• Coverslips, 24x24 mm (Menzel-Gläser) 
• Aluminum foil (Co-op Supermarket, Alustar) 
• 0.22 micron filter sterilizers (TPP, cat. no. 99500) 
• Orbital shaker (Labnet, Orbit 1000)  
• Parafilm (Pechiney Plastic Packaging, cat. no. PM-996) 
• Marked 15 cm silicon plate (see Equipment Setup) 
• 50 ml syringe (Braun, cat. no. 4610083F) 
• 18 G syringe needles (Milian, cat. no. 921030)  
• Whatman paper (VWR, cat. no. 10426892)  
• Benchkote paper (Whatman, cat. no. 2300731) 
• 15 cm cell culture dish (TPP, cat. no. 93150) 
• 10 cm cell culture dish (TPP, cat. no. 93100) 
• 6-well cell culture dish (TPP, cat. no. 92406) 
• 12-well cell culture dish (TPP, cat. no. 93412) 
• 50 ml tube (TPP, cat. no. 91050) 
• Paraffin embedding cassette (Biosystems, 81-0035-00) 
• Fluorescent stereomicroscope (e.g. Leica M205FA) 
• Heated block (e.g. Desaga, Thermoplate S) 
• Microwave oven (e.g. Sharp) 
• FIJI software http://fiji.sc/Fiji 
• Lymphatic vessel analysis protocol (LVAP) FIJI plugin29 
(http://www.ludwig.edu.au/archive/RaminShayan2008/index.html) 
 
REAGENT SETUP 
10X PBS 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 2 mM KH2PO4. 
Dissolve 2 g KCl, 80 g NaCl, 6.1 g Na2HPO4 and 2 g KH2PO4 in 1 L water. Adjust 
the pH to 7.4 with NaOH and autoclave. Store at RT (24°C). 1X PBS can be made by 
diluting 10X PBS 1:10 and stored at RT for mouse perfusion and at 4°C for all other 
uses and stored for months. 
 
1M Phosphate buffer, pH 7 To make 500 ml, mix 195 ml 1M NaH2PO4 with 305 
ml 1M Na2H2PO4 and filter sterilize. Can be stored for months at RT. 
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4% (wt/vol) paraformaldehyde solution Weigh 40g of PFA and mix with 1L of 1X 
PBS at 60ºC until dissolved. Filter sterilize, make 50ml aliquots and store at -20ºC for 
up to 6 months. Once thawed, store at 4ºC for up to 7 days then discard. Use at RT for 
perfusion, all other uses at 4°C.  
CAUTION- Paraformaldehyde is a hazardous reagent; use a chemical fume hood and 
wear protective gloves and mask when you are preparing the fixative. Protect from 
light. 
CRITICAL- Plan 3 hours for dissolving, filtering and aliquoting the 4% PFA. 
 
Fixation solution 0.5% (wt/vol) paraformaldehyde, 15% (vol/vol) picric acid, 100 
mM phosphate buffer, pH 7. To make 250 ml mix 31.25 ml 4% paraformaldehyde, 
37.5 ml picric acid, 25 ml 1M phosphate buffer, pH 7 and 156.25 ml water. 
CRITICAL: Prepare fresh before beginning dissection and store at 4ºC. Discard after 
finishing dissection.  
CAUTION-Picric acid is a hazardous reagent; use a chemical fume hood and wear 
protective gloves and mask when you are preparing the fixative. 
 
Xylosol/Ketasol mix For 5 ml mix 500ul Ketasol with 400ul Xylosol and bring up to 
5 ml with 1X PBS. Discard after finishing dissection. 
CRITICAL- Protect from light.  
 
PBS+ 1 mM EDTA To make 500 ml, add 1 ml of 500mM EDTA to 499 ml of 
1xPBS. Can be stored for months at 4ºC. 
 
10% (vol/vol) sucrose solution Add 50 g sucrose to 450 ml of PBS. Once the sucrose 
is dissolved, add 1X PBS to 500 ml, filter sterilize. Can be stored for months at 4ºC. 
 
20% (vol/vol) sucrose solution+10% glycerol Add 100 g sucrose and 57.5 ml 87% 
glycerol to 450 ml of PBS. Once the sucrose and glycerol are dissolved, add 1X PBS 
to 500 ml, filter sterilize. Can be stored for months at 4ºC. 
 
Donkey serum Heat inactivate donkey serum at 65°C for 30 min., let cool, filter 
sterilize and make 10 ml aliquots. Can be stored for months at -20°C. 
 
Blocking buffer 5% (vol/vol) donkey serum, 0.5% (wt/vol) bovine serum albumin 
(BSA), 0.3% (vol/vol) Triton X-100, 0.1% (wt/vol) NaN3. n 300 ml of 1X PBS 
dissolve 2.5 g BSA, 0.5 g NaN3, 25 ml of donkey serum, and 1.5 ml Triton X-100. 
Add 1X PBS to 500 ml and filter sterilize. Can be stored for months at 4°C. 
 
Wash buffer 1X PBS, 0.3% (vol/vol) Triton X-100. Add 3 ml Triton X-100 to 1 L 
1X PBS, shake vigorously. Can be stored for months at 4°C. 
 
PBS+NaN3 1X PBS, 0.1% (wt/vol) NaN3. Add 1 g of NaN3 to 1 to 1 L 1X PBS, 
shake vigorously. Can be stored for months at 4°C. 
 
M.O.M. Blocking reagent in 1X PBS Add one drop of blocking reagent to 2.5 ml of 
1X PBS. CRITICAL: Make fresh and discard any extra after blocking. 
 
 
EQUIPMENT SETUP 
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Perfusion apparatus Fill one infusion bag with room temp. 1X PBS and one bag 
with room temp. 4% PFA. Arrange tubing so that each bag drains to a 3-way 
stopcock. At the third position of the 3-way stopcock attach the Small Animal 
Butterfly Catheter. Run 1X PBS and 4% PFA until all bubbles are removed from 
tubing. If a perfusion apparatus is not readily available a 20 ml syringe filled with 4% 
PFA and fitted with a 25 G needle can be substituted to perfuse the mice. 
Silicone plates Mix the curing agent well with the silicone according to 
manufacturer’s directions in a fume hood. Immediately, pipette approximately 25 ml 
of silicone into each of either 10 cm, 6-well or 12 well culture dish. Pipette 
approximately 35 ml of silicone into 15 cm culture dish. Distribute all silicone onto 
culture dishes of various sizes. Leave in hood to cure for 4 days before use. After 4 
days wash with soap and water and sterilize with 70% (vol/vol) ethanol. Plates can be 
recycled after use by removing any remaining tissue and washing as above. 
CRITICAL- Using the silicone plates before the end of the 4 day cure will result in 
detachment of the silicone from the culture dish. 
Marked 15 cm silicone plate Using a ruler, make 1 cm markings on 15 cm silicone 
plate with an indelible lab pen. For ease of use, invert numbers labeling the marks 
such that the numbers are readable when looking from the top down.  
Whatman paper disc Draw a circle with a pencil on Whatman paper using a 10 cm 
cell culture dish as a model. Cut out circle with scissors. Use scissors to further cut 
the Whatman paper to reduce the circle diameter so it easily fits inside a 10 cm cell 
culture dish. 
Benchkote paper-coated dish Draw a circle with a pencil on Benchkote paper using 
a 15 cm cell culture dish as a model. Cut out circle with scissors. Use lab tape to 
attach Benchkote paper, plastic side up, to the bottom of a 15 cm cell culture dish. 
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PROCEDURE  
 
Day 1: Mouse perfusion, tissue dissection, preparation and fixation. Timing: 6-
8h 
CRITICAL: Good perfusion fixation is necessary to prevent intestine degradation 
and allow long-term storage. Poorly fixed whole-mount intestinal samples tend to 
degrade very quickly during storage. A detailed video and protocol is available from 
Gage et al.25  
1. Anaesthetize the animal as approved in the animal experimentation 
protocol (e.g. by injecting 15µl/ g mouse of Xylosol/Ketasol mix). Wait 5-
10 minutes until there is no response to the foot pinch test. 
2. Transfer the mouse to the fume hood containing the perfusion apparatus 
and place the animal in a supine position. Spray the mouse with 70% 
EtOH to prevent hair contaminating the intestine sample. Make an incision 
in the skin from the gonadal region to just under the neck and remove the 
skin to expose the thorax.  
3. Make an incision between the ribs and continue cutting in a dorsal 
direction following the contours of the ribcage until the other side of the 
animal is reached. Cut enough of the ribcage to be able to easily lift and 
expose the heart. 
4. Start pumping 1X PBS through the perfusion apparatus. Cut the right 
atrium with small scissors and insert the perfusion needle into the left 
ventricle. 
5. Allow 1X PBS perfusion to continue for 30-60 seconds then switch to 4% 
PFA solution. Allow 4% PFA solution to perfuse for 2-3 minutes. 
Troubleshooting 
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CRITICAL STEP: Good perfusion fixation is necessary to prevent 
intestine degradation and to allow long-term storage. Poorly fixed whole-
mount intestinal samples tend to degrade very quickly during storage. 
Furthermore, proper perfusion fixation is critical for successful 
implementation of the WM/EP(-) protocol by allowing efficient removal 
of intestinal epithelial cells without villus destruction. 
CAUTION PFA is toxic, only perform PFA perfusion in a well-ventilated fume hood.  
6. After completion of perfusion make an incision in the abdominal cavity to 
expose the intestine. Cut the colon as near to the rectum as possible and 
cut the duodenum as near to the stomach as possible. 
7. Slowly pull out the duodenum to remove the pancreas and mesentery. 
Periodic pulling of the mesentery with the forceps while pulling the 
duodenum may be necessary to completely remove the mesentery. Place 
the entire small intestine, cecum and colon into the marked 15 cm silicon 
plate with ice-cold 1X PBS on ice.  
8. Measure and record the length of the small intestine from the pyloric 
sphincter to the cecum. Cut the small intestine at the junction with the 
cecum. Using the ruler on the 15 cm silicone plate cut 5 cm down from the 
pyloric sphincter and label as duodenum. The rest of the length is 
considered the jejunum and ileum. Cut this piece in half and use the upper 
part as jejunum and lower part as ileum (Figure 3). Cut the colon from the 
cecum. Secure tissue with one pin on the upper end of each dissected piece 
of intestine to keep the pieces organized. 
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Critical step: During the tissue dissection procedure it is important to keep track of 
the upper end of each of the pieces. This is critical for downstream analysis to be 
able to compare similar regions of the intestine among different animals. 
9. Using the 50 ml syringe fitted with an 18G needle, flush the gut contents 
from each of the small intestine pieces by fully flushing from both ends. 
Because the colon muscles tightly hold feces, the colon cannot be flushed 
in the same manner; instead, cut the colon lengthwise using artery scissors 
and remove feces manually or by gentle shaking in 1X PBS. 
Troubleshooting 
10. Cut the duodenum, jejunum and ileum open lengthwise using artery 
scissors. Pin the upper end of each part to the 15 cm marked silicone dish. 
11. (OPTIONAL) If intending to perform simultaneous analysis on whole-
mount and paraffin-embedded samples (see Supplementary Method 1), 
divide the jejunum and ileum into the appropriate number of equal pieces 
and designate one piece for each different treatment (i.e. WM/EP(+), 
WM/EP(-) or paraffin). Mark the upper ends of the pieces designated for 
WM/EP(-) with a small cut with the scissors.  
CRITICAL STEP: removal of epithelial cells for WM/EP(-) is not efficient 
in the duodenum, therefore the upper duodenum half should be used for 
paraffin embedding and the lower part for WM/EP(+). 
12. Perform post-fixation of the intestinal pieces according to Option A for 
WM/EP(+), Option B for WM/EP(-), or Supplementary Method 1 for 
paraffin embedding. 
A. WM/EP(+) Timing: 10 minutes 
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i. Pin the piece of intestine for WM/EP(+)onto a 10 cm 
silicone plate containing 1X PBS using insect pins 
(Figure 4a). First pin the top of the intestine at 1 cm 
intervals, then pin the bottom, making sure the intestine is 
flush with the silicone plate.  
ii. Rinse the pinned intestine in the 10 cm silicone plate once 
with ice-cold 1X PBS. 
iii. Add fixation buffer until intestine pieces are fully 
submerged. Incubate the samples on an orbital shaker 
overnight (O/N) at 4°C. 
B. WM/EP(-) Timing: 20 minutes 
i. Place pieces on intestine for WM/EP(-) into 25 ml of 
1mM EDTA PBS solution in a 50 ml tube and gently 
shake to submerge. Leave on ice for 5 min. 
ii. Gently shake again and then leave on ice for 5 min.  
iii. Transfer the pieces of intestine back to the 15 cm silicone 
plate in ice-cold 1X PBS. 
iv. Pin the piece of intestine for WM/EP(-) onto a 10 cm 
silicone plate containing 1X PBS using insect pins 
(Figure 4a). First pin the top of the intestine at 0.5 cm 
intervals, then pin the bottom, making sure the intestine is 
flush with the silicone plate.  
Critical step: WM/EP(-) pieces should be pinned tightly, flush with the plate, with 
no “loose” intestine. Otherwise, the following epithelial cell removal step is more 
difficult. 
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v. Use the end of closed large forceps to gently “brush” off 
villus epithelial cells (Figure 4b, c). Do not press down on 
the tissue while brushing or intestinal villus stroma will 
also be brushed away. 
Troubleshooting 
vi. Rinse the pinned intestine in the 10 cm silicone plate once 
with ice-cold 1X PBS. 
vii. Add fixation buffer until intestine pieces are fully 
submerged. Incubate the samples on an orbital shaker 
O/N at 4°C. 
 
Day 2: Sample washing. Timing: 1-2h 
13. Remove fixation buffer from 10 cm silicone dishes containing pinned 
intestine (from step 12A(iii) or 12B(vii)) and replace with ice-cold 1X 
PBS.  
14. Wash on an orbital shaker, 4°C for 5 min. Repeat two more times. 
Caution: Removal of fixation buffer must be done in fume hood. 
15. After last wash with 1X PBS, remove 1X PBS and replace with 10% 
sucrose solution.  
16. Incubate the samples on an orbital shaker for 3 hours at 4°C. 
17. Remove 10% sucrose solution and replace with 20% surcrose+10% 
glycerol solution. 
18. Incubate the samples on an orbital shaker O/N at 4°C. 
 
Day 3: Primary antibody incubation. Timing: 4-5h 
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19. Remove 20% surcrose+10% glycerol solution, rinse once with ice-cold 1X 
PBS, and submerge intestine pieces in PBS+NaN3. 
Pause point: Seal plates with parafilm. Samples can be stored at 4ºC for up to 
several months. 
20. Using a dissection microscope to visualize the intestine, cut it into 0.5-1cm 
long pieces and transfer them to a 6- or 12- well silicone plate and re-pin 
with 4 pins/ piece. Up to two pieces can fit in one well of a 12-well plate; 
up to 5 pieces can fit in one well of a 6-well plate (Figure 4d). 
Critical step: When comparing the same immunostaining among several mice 
(e.g. wild-type vs mutant mice), make sure to take a 1 cm long piece from the 
corresponding place on the intestine from each mouse.  
21. Add blocking buffer to samples; use 1 mL/well for a 12-well plate or 2 
mL/well for a 6-well plate. Incubate the samples on an orbital shaker for 1-
2h at 4°C. 
22. Prepare an appropriate primary antibody mix in blocking buffer. Prepare 1 
mL/well for a 12-well plate or 2 mL/well for a 6-well plate. Table 2 
outlines combinations of primary and secondary antibodies we have used 
successfully. For example, staining for Pecam1 and Lyve1 will allow 
analysis of lacteal length (see Step 45A), staining for Vegfr3 will allow 
visualization of lacteal filopodia (step 45C), and staining with Vegfr2 will 
allow analysis of blood vessel length and branching and blood vessel 
filopodia (Step 45B and D) 
CRITICAL STEP- Primary antibodies can be omitted or replaced with antibodies 
from the same species and of the same isotype as a negative control. 
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23. Remove blocking buffer from samples and add primary antibody mix. 
Incubate the samples on an orbital shaker O/N at 4°C. 
 
Day 4: Primary antibody washing and secondary antibody incubation. 
Timing: 6h 
24. Remove primary antibody mix and add ice-cold PBS+0.3% Triton-X100. 
Wash on an orbital shaker, 4°C for 1h. Repeat 4 more times. 
25. Prepare an appropriate secondary antibody mix in blocking buffer. Prepare 
1 mL/well for a 12-well plate or 2 mL/well for a 6-well plate. 
26. Replace PBS+0.3% Triton-X100 with secondary antibody mix. Incubate 
the samples on an orbital shaker O/N at 4°C. 
Critical step: Although primary antibodies can be left on samples for several days, 
secondary antibodies cannot. Let secondary antibodies incubate for a maximum of 
16 hours at 4°C. 
 
Day 5: Secondary antibody washing and post-immunostaining fixation. 
Timing: 6h 
27. Remove secondary antibody mix and add ice-cold PBS+0.3% Triton-
X100. Wash on an orbital shaker, 4°C, 10 times for 30 min each. At this 
point, samples can be analyzed using a fluorescent stereomicroscope to 
determine that primary and secondary antibody immunostaining worked. 
28. Replace PBS+0.3% Triton-X100 with ice-cold 1X PBS and wash twice for 
10 min. each at 4°C on an orbital shaker. 
29. Replace 1X PBS with ice-cold 4% PFA. Incubate the samples on an orbital 
shaker for 2 days at 4°C. 
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CAUTION PFA is toxic, only work with PFA in a well-ventilated fume hood. 
 
Day 6: Mounting. Timing: 6h 
30. Remove 4% PFA and add ice-cold PBS. Wash on an orbital shaker, 4°C, 3 
times for 30 min each.  
Caution: Remove 4% PFA in fume hood. 
31. Label microscope slides with sample ID and antibodies used in 
immunostaining 
32. Remove the protective cover of one sticky side of the spacers and stick 
onto microscope slide. Leave the other sticky side untouched. 
33. Transfer plate to dissection microscope. Work in as little light as possible 
and use the bottom lamp of the dissection microscope to look at the 
samples.  
34. Move pins away from two corners using small forceps to leave a strip 2-3 
mm wide that remains flush with the silicone. Focus the microscope with 
the highest magnification on the bottom corner. 
35. Use very fine scissors to cut a strip of intestine, trying to make it one or 
two villi wide. Cutting into the silicone gel under the intestinal sample 
facilitates obtaining a good strip. When it is cut, you can gently move the 
strip out of the way and begin to cut the next strip (Figure 4e). 
Troubleshooting 
36. Repeat step 35 to obtain a total of 10-15 strips. 
37. Use very fine forceps to place the strips on the glass slide inside the spacer 
area. 
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38. Using a paper towel or tissue paper absorb excess PBS by placing it near 
intestinal strips. 
39. For WM/EP(+) samples only, place 2 drops of FocusClear on intestine 
strips, use very small forceps to spread out the strips as much as possible 
and incubate for at least 20 minutes (maximum 25 minutes) at room 
temperature. Use P200 micropipettor to remove as much FocusClear as 
possible. 
40. Add 2-3 drops of Prolong Gold mounting medium to intestine strips. Tilt 
slide around to help spread out the mounting medium. 
41. Use very fine forceps to arrange the strips horizontally and vertically so 
they all fit inside the area of the spacer. Intestine strips should also be 
placed so that villi are clearly visible and submucosa does not fold over on 
top of villi (Figure 4f). 
42. Remove upper spacer cover, leaving the upward surface of the spacer 
sticky, and firmly affix the coverslip. 
43. Smear excess mounting medium around the edges of the coverslip to seal 
the coverslip to the slide.  
44. Place in slide storage box at 4°C. 
Pause point: If samples are kept at 4°C and mounting medium remains, slides can 
be kept for up to a year. 
 
Day 7: Confocal microscopy. Timing: 6-8h 
45. Acquire images for the vessel parameter to be analyzed. If WM staining 1 
(see Table 2) was performed, lacteal length (Option A) and lacteal filopodia 
(Option C) can be analyzed. If WM staining 2 (see Table 2) was performed, 
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blood vessel length and branching (Option B) and blood vessel filopodia 
(Option D) can be analyzed. 
A. Lacteal length 
i. Image mounted samples with WM staining 1 using the 488 and 633 
nm lasers with the 20X objective of a confocal microscope, so that 
Pecam1 and Lyve1 staining on several villi can be imaged 
simultaneously on a single image (Figure 5a). Adjust the z-stack so that 
whole villi can be imaged (usually 80-100 μm) and set z-stack step size 
as recommended by image acquisition software. Take images from 10-
15 different regions in each sample. 
B. Blood vessel length and branching 
i. Image mounted samples with WM staining 2 using the 555 nm laser 
with the 20X objective of a confocal microscope, so that Vegfr2 
staining on several villi can be imaged simultaneously on a single 
image (Figure 5a). Adjust the z-stack so that whole villi can be imaged 
(usually 80-100 μm) and set z-stack step size as recommended by 
image acquisition software. Take images from 10-15 different regions 
in each sample. 
C. Lacteal filopodia  
i. Examine mounted samples with WM staining 1 using the orange 
filter of a fluorescent microscope, to analyze Vegfr3, with the 63X 
objective. Count the number of filopodia/ lacteal blinded and record on 
spreadsheet for appropriate analysis. 
D. Blood vessel filopodia 
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i. Examine mounted samples with WM staining 2 using the orange 
filter of a fluorescent microscope, to analyze Vegfr2, with the 63X 
objective. Count the number of blood vessel filopodia/villus blinded 
and record on spreadsheet for appropriate analysis. 
Troubleshooting 
 
Day 8: Image analysis. Timing: 6-8h 
46. Analyze confocal images obtained at step 45A as outlined in Option A. 
Use Option B to analyze images obtained as described in step 45B. 
A. Lacteal length 
i. Import images from step 45A into FIJI, convert into maximum intensity 
projections to view the complete z-stack and import into the LVAP FIJI 
plugin. Using the “Total Width” counter, measure the lacteal length from 
the lacteal tip to the bottom (Figure 5a).  
ii. Using the “Intervessel Distance” counter, measure the blood vessel 
network length from the top of the villus to the bottom (same bottom as for 
lacteal measurement (Figure 5a).  
iii. Click “measure” and cut and paste data to a spreadsheet for appropriate 
analysis.  
iv. Divide the lacteal length by villus length, multiply by 100 to obtain 
relative lacteal length. 
B. Blood vessel length and branching 
i. Import images from step 45B (Figure 5b) into FIJI, convert into maximum 
intensity projections to view the complete z-stack and import into the 
LVAP FIJI plugin. Make images binary (Process>Binary>Make Binary) 
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and adjust settings (dilate, open, close) until blood vessel network is clear 
(Figure 5c). 
Critical step: Use the same settings for all analyses from one experiment. 
ii. Click “Skeletonize” (Process>Binary>Skeletonize) to draw vessel network 
outline (Figure 5d). 
iii. Click “Analyze Skeleton” (Plugins>Skeleton>Analyze Skeleton) for 
network quantification. 
iv. Cut and paste data for branchpoints and length into a spreadsheet for 
analysis.  
v. Calculate vessel length and branching/vessel length for each sample. 
Troubleshooting 
  
 28 
TROUBLESHOOTING 
Troubleshooting advice is provided in Table 3. 
 
TIMING 
Day 1:Steps 1-12, mouse perfusion, tissue dissection, preparation and fixation: 6-8h 
Day 2: Steps 13-18, sample washing: 1-2h 
Day 3: Steps 19-23, primary antibody immunostaining: 4-5h 
Day 4: Steps 24-26, primary antibody washing and secondary antibody 
immunostaining: 6h 
Day 5: Steps 27-29, secondary antibody washing and post-immunostaining fixation: 
6h 
Day 6: Steps 30-44, WM mounting: 6h 
Day 7: Step 45, confocal microscopy: 6-8h 
Day 8: Step 46, image analysis: 6-8h 
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ANTICIPATED RESULTS 
We have used this intestine whole-mount protocol to obtain high-resolution 3D 
images of intestinal villus stroma by immunostaining with a variety of antibodies13. 
The resolution obtained allows many different analyses to be performed on the same 
samples. Proper preparation, clearing, immunostaining and mounting will allow full 
visualization of both lymphatic and blood vessels in the villus and submucosal 
intestine (Figure 5a) and detection of lymphatic and blood filopodia (Figure 5e, f). 
Loss of 3D villus structure, incomplete immunostaining in the submucosal vessels 
and inability to detect vessel filopodia are all indicators of reduced quality (see Table 
3). Co-immunostaining with Pecam1 and Lyve1 allows accurate determination of 
lacteal length and blood vascular density (Figure 5a). Furthermore, immunostaining 
with Vegfr2 allows precise measurement of villus blood capillary length and 
branching (Figure 5b). In addition, this protocol allows the visualization of blood 
capillary and lacteal filopodia and organization of intercellular junctions (Figure 5e, f 
and ref. 13). The protocol can be combined with the conventional “Swiss roll” 
protocol for paraffin embedding, allowing measurement of endothelial cell 
proliferation by staining for Ki67, lymphatic endothelial transcription factor Prox1 
(Figure 5g) and pan-endothelial transcription factor Erg (not shown). By using this 
procedure we are also able to visualize most stromal cell types and components in the 
small intestine, such as neurons, immune cells, pericytes, smooth muscle cells, 
fibroblasts and extracellular matrix proteins (Figure 2 and ref. 13). We anticipate this 
protocol will be used to investigate cell morphology, position and cell-cell 
interactions in the intestine for researchers from a plethora of fields, as well as serve a 
standard tool in the vascular biology toolbox for the study of both vessel patterning 
and specialized function. 
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FIGURE LEGENDS 
Figure 1: Whole-mount immunostaining allows high-resolution imaging of 
intestinal stroma. (a) Image comparison of intestinal villus blood capillaries (red) 
and lymphatic lacteals (green) obtained using either paraffin section (left) or whole-
mount immunostaining (right). Blood capillaries stained with either Meca32 (left) or 
Pecam1 (right); lacteals stained with Lyve1; nuclei stained with DAPI (blue, left). (b) 
Image comparison of intestinal villus blood capillaries (red, Vegfr2) obtained using 
either thick cryosections (200 μm, top) or whole-mount staining (bottom). Blood 
endothelial cell nuclei are stained for Erg (green). Scale bars: 50 μm: a; 20 μm: b. 
Animal experiments were approved by the Animal Ethics Committee of Vaud, 
Switzerland. 
 
Figure 2: All intestinal stromal cell types can be visualized with intestinal whole-
mount immunostaining. (a) Whole-mount immunostaining of villus blood 
capillaries (red, Vegfr2) and neurons (green, Pgp9.5). Note close association of 
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neurons and blood capillaries. (b) Whole-mount immunostaining of intestinal villus 
lacteal (red, Lyve1), smooth muscle cells (SMCs; cyan, αSMA) and macrophages 
(green, F4/80). (c) Cell-cell interactions can be easily observed as a subset of villus 
SMCs (cyan, αSMA) are also in contact with lacteals (red, Lyve1). (d) CD11b+ (red) 
and CD3+ (violet) immune cells are readily visualized in close proximity to villus 
SMCs (cyan, αSMA) using intestinal whole-mount staining. (e) Vimentin+ fibroblasts 
(green) and villus SMCs (red, αSMA) imaged using intestinal whole-mount 
immunostaining. (f) The extracellular matrix protein tenascin C (green) can be 
visualized around blood capillaries (red, Vegfr2) and throughout the entire villus by 
whole-mount immunostaining. (g) Fibronectin (green) can be observed highly 
expressed in villi, especially on villus SMCs (red, αSMA). Images with epithelial 
cells (WM/EP(+)): a, b, c, d. Images without epithelial cells (WM/EP(-)): e, f, g. Scale 
bars: 50 μm: a, b, d; 20 μm: c, e, f, g. Animal experiments were approved by the 
Animal Ethics Committee of Vaud, Switzerland. 
 
Figure 3: Experimental outline for preparing intestine for simultaneous imaging 
by paraffin sectioning, whole-mount with epithelial cells (WM/EP(+)) and whole-
mount without epithelial cells (WM/EP(-)). The small intestine is dissected, cleaned 
and divided into the duodenum (duo), jejunum and ileum. These pieces can then be 
further partitioned for use in paraffin sections, WM/EP(+) or WM/EP(-) and fixed. 
The piece for paraffin sectioning is prepared in a Swiss roll and further processed as 
described in Supplementary Method 1, while the pieces for WM are pinned to silicone 
plates and epithelial cells are removed from the piece dedicated to WM/EP(-). One 
cm pieces are then cut and transferred to 6- or 12-well plates for immunostaining. 
After staining, fine scissors are used to cut strips of the intestine 2-3 villi thick and 
samples dedicated to WM/EP(+) are cleared using a commercial clearing agent. These 
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villi strips are then carefully positioned to be flat against the slides inside the spacer 
and coverslips are affixed prior to confocal microscopy.  
 
Figure 4: Experimental details. (a) After dissection, but before addition of fixation 
buffer, the whole intestine is pinned on 10 cm silicone-coated dishes. An example is 
shown on how to pin the whole intestine including both pieces for WM/EP(+) and 
WM/EP(-). (b, c) Whole-mount pinned intestine for WM/EP(-) before (b) and after 
(c) scraping off epithelial cells. (d) 1 cm intestinal pieces pinned into a silicone-
coated 6-well dish for whole-mount immunostaining. (e) An example of cutting villi 
strips for whole-mount immunostaining. (f) An example of mounted villi strips, 
stained for Lyve1 (white), placed correctly on a microscope slide. Scale bars: 1 mm: 
b, c, f; 500 μm: e. Animal experiments were approved by the Animal Ethics 
Committee of Vaud, Switzerland. 
 
Figure 5: Expected results. (a) Intestinal whole-mount image for measuring lacteal 
length as a percentage of the blood capillary network length. Lacteals (red, Lyve1) 
and blood capillaries (green, Pecam1) are imaged using a 20X objective of a confocal 
microscope. Lacteal length (white bars) and blood capillary network length (yellow 
bars) are measured and lacteal length is calculated as lacteal length/ blood capillary 
network length. (b, c, d) Intestinal whole-mount imaging for measuring blood 
capillary vessel length and branching. (b) Blood capillaries (red, Vegfr2) are imaged 
using the 20X objective of a confocal microscope. (c) The images are imported into 
FIJI and converted into binary images. (d) Using FIJI the binary images are 
skeletonized and the resulting network analyzed for length and branching. (e) Blood 
capillary filopodia (green, Vegfr2; arrowheads) can be easily visualized and counted 
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after whole-mount immunostaining. (f) Lacteal filopodia (red, Lyve1; arrowheads) 
can be easily visualized and counted after whole-mount immunostaining. 
Immunostaining for Vegfr3 can also be effectively used for counting lacteal filopodia. 
(g) Example paraffin section image of lymphatic endothelial cells positive (white, 
Prox1+Ki67+, arrowhead) or negative (red, Prox1+, arrow) for Ki67 (green). DAPI 
stained nuclei are blue. Scale bars: 100 μm: a; 50 μm: b; 20 μm: e, f, g. Animal 
experiments were approved by the Animal Ethics Committee of Vaud, Switzerland. 
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TABLES 
Table 1: Comparison of different methods for intestinal imaging  
Method Sample thickness 
3D 
imaging? 
Lateral 
imaging? 
Clearing 
necessary? 
Filopodia 
detection? 
Paraffin/frozen 
thin sections 1-5μm no yes no no 
Frozen thick 
sections 5-200μm no yes no no 
Stappenbeck et al. 
whole-mount10 
whole 
villus partial no no no 
Fu et al. and 
Appleton et al. 
whole-mount22,23 
whole 
villus yes no yes no 
Small intestinal 
whole-mount13 
whole 
villus yes yes yes yes 
 
Table 2: Whole-mount immunostaining antibody mixes 
  Primary antibodies 
Dilution 
Secondary 
antibodies 
Dilution 
Antibody 
against: (final conc.) (final conc.) 
 Pecam1 
1:400 donkey 
anti-rat 
Alexa 488 
1:500 Blood and 
lymphatic 
vessels 
(1.25 
μg/ml) (4 µg/ml) 
Staining 
1* Vegfr3 
1:100 donkey 
anti-goat 
Alexa 555 
1:500 Lymphatic 
vessels and 
filopodia (1 μg/ml) (4 µg/ml) 
 Lyve1 
1:500 donkey 
anti-rabbit 
Alexa 647 
1:500 Lymphatic 
vessels and 
filopodia (2 μg/ml) (4 µg/ml) 
Staining 
2 Vegfr2 
1:100 donkey 
anti-goat 
Alexa 555 
1:500 
 
(4 µg/ml) 
Blood vessels 
and filopodia (1 μg/ml) 
 
*Primary antibodies can be omitted or replaced with antibodies from the same species 
and of the same isotype as a negative control. 
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Table 3: TROUBLESHOOTING 
Step Problem Possible reason Solution 
5 Poor perfusion 
Puncture of 
the ventricle 
septum or 
outer heart 
wall 
Gently insert needle into left 
ventricle to start perfusion. 
Once the needle is inserted, do 
not move it, rather let the 
needle rest on the mouse. If 
there are multiple punctures 
try to squeeze heart together 
with forceps and perfusion 
needle while perfusing. 
9 
Inefficient 
intestine 
flushing 
Holes in 
intestine from 
18 G needle 
The 18 G needle can be 
substituted by a rounded 
gavage needle 
12B(v) 
Epithelial cells 
do not come off 
easily 
Poor fixation 
Good perfusion fixation is 
critical for epithelial cells to 
be easily scraped off with the 
forceps. Poor perfusion makes 
it very difficult to remove the 
epithelial cells without tissue 
damage. 
12B(v) 
Epithelial cells 
do not come off 
easily 
Not enough 
pins 
Place one pin every 0.5 cm on 
both the top and bottom of the 
opened intestine to avoid 
"loose" intestine. Loose 
intestine makes easily 
scraping of epithelial cells 
difficult. 
35 
Unable to cut 
intestine strips 
for mounting 
Using 
wrong/dull 
scissors 
Sharp, very small scissors are 
necessary to properly cut the 
tissue. Also, cutting into the 
silicone gel also helps make 
better intestine strips. 
45A-D 
Villus size is 
significantly 
different among 
samples 
Not keeping 
intestine in 
right order 
during 
dissection  
While organizing intestinal 
tissue during processing for 
whole-mount and paraffin 
immunostaining always keep 
one pin in the upper part of the 
piece to keep of directionality 
(steps 10-11). 
 38 
45A-D Immunostaining background 
Intestine not 
cleaned 
enough 
Fully clean intestine by 
flushing in both directions and 
shaking in 1X PBS. If 
intestine is not properly 
cleaned the tissue degrades 
more quickly and has more 
background after 
immunostaining (Step 9). 
45A-D 
Villus size is 
significantly 
different among 
samples 
Not keeping 
intestine in 
right order 
during 
dissection 
To note the upper part of the 
intestine for the WM/EP(-) 
preparation, make a small 
notch in the upper part of the 
intestinal pieces with very 
small scissors (Step 11).  
45A-D 
Immunostaining 
only on villus 
tips 
Primary 
antibody 
incubation 
time is too 
short 
Increase primary antibody 
incubation time. Primary 
antibodies can be left on for 
several days without an 
increase in background (Step 
23). 
46B 
Skeletonized 
outline of blood 
vessels doesn’t 
match image 
Low quality 
images 
Blood vessel networks can be 
drawn by hand using photo 
processing software (e.g. 
Photoshop) and imported into 
FIJI for network analysis 
 
 
SUPPLEMENTARY INFORMATION 
Supplementary Figure 1: Example of necessity for WM/EP(-) protocol where strong 
epithelial staining prevents stroma visualization in most villi. Whole-mount 
immunostaining of intestinal villi for Dll4 (cyan). Dll4 is highly expressed in 
intestinal epithelial cells preventing visualization of stromal Dll4 (outlined). Scale 
bar: 50 μm. 
Supplementary Method 1: Preparation, immunostaining, imaging and quantification 
of intestinal paraffin sections  
Supplementary Table 1: Antibodies tested for whole-mount and paraffin section 
immunostaining. 
Supplementary Table 2: Paraffin immunostaining antibody mix 
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Supplementary Table 3: Blood and lymphatic endothelial cell proliferation analysis 
strategy 
Supplementary Table 4: Troubleshooting for Supplementary Method 1 
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Supplementary Figure 1 
Example of necessity for WM –EP protocol where strong epithelial staining prevents stroma visualization in most villi. 
Whole-mount immunostaining of intestinal villi for Dll4 (cyan). Dll4 is highly expressed in intestinal epithelial cells preventing 
visualization of stromal Dll4 (outlined). Scale bar: 50 μm.  
Supplementary Information 
 
High-resolution 3D analysis of mouse small intestinal stroma 
  
Jeremiah Bernier-Latmani and Tatiana V. Petrova 
 
1 Supplementary Method  
4 Supplementary Tables   
Supplementary Method 1- Preparation, immunostaining, imaging and 
quantification of intestinal paraffin sections  
Day 1: Dissection and fixation. Timing: 6-8h 
1. Place pieces of intestine designated for paraffin embedding (from Main 
Protocol, step 11) on a Benchkote paper 15 cm dish. Use a dissection 
microscope position to ensure the intestinal pieces are placed luminal side 
down. Use small forceps to spread intestinal pieces flat. 
2. Once intestinal pieces are well positioned, place the 10 cm Whatman disc on 
top of them and press gently, yet firmly, down to stick the pieces to the 
Whatman disc. Gently pull the Whatman disc up; the intestinal pieces should 
be stuck villi-up onto the Whatman paper. Use small forceps to spread 
intestinal pieces flat. 
3. Place the intestinal pieces on the Whatman paper into a regular 10 cm cell 
culture dish and fill with 4% paraformaldehyde until the intestinal pieces are 
fully submerged. Incubate the samples on an orbital shaker O/N at 4°C. 
Troubleshooting 
Day 2-3: Washing and paraffin embedding. Timing: 2 days  
4. Remove 4% PFA and replace with ice-cold 1X PBS. Wash on orbital shaker, 
4°C for 10 min. Repeat three more times. 
Caution: Removal of 4% PFA must be done in fume hood. 
5. After last 1X PBS wash prepare intestine pieces for Swiss roll. Roll pieces of 
intestine (villi inside) and fix with two pins/ roll. 
6. Place all pieces from one mouse in marked cassette and close cassette. 
Submerge cassette in ice-cold 70% EtOH. 
Pause point: Incubate the samples 4°C until paraffin embedding. 
7. Remove insect pins from samples, embed in paraffin and cut 5 µm thick 
sections. 
Day 4: Primary antibody immunostaining. Timing: 3h 
8. Place slides with paraffin sections on a heated block at 60°C for 10 min to melt 
wax. 
9. Immediately transfer slides to 100% xylene and agitate by hand for 3 minutes 
to deparaffinize the slides. 
Troubleshooting 
Critical step: It is important to transfer the warm slides as quickly as possible to the 
xylene bath to ensure efficient deparaffinization. 
10. Repeat step 2 twice more in new xylene baths agitating for 2 minutes each. 
11. Transfer slides to 100% EtOH bath and agitate for 2 minutes. 
12. Repeat step 4 twice more in new 100% EtOH baths agitating for 2 minutes 
each. 
13. Transfer slides to 90% EtOH bath and agitate for 2 minutes. 
14. Transfer slides to 70% EtOH bath and agitate for 2 minutes. 
15. Transfer slides to water bath, briefly agitate and replace water. 
16. Pour enough 1X high pH retrieval buffer to cover slides. 
17. Cook slides in microwave at high heat for 5 min. 
18. Open microwave and examine levels of retrieval buffers. If the slides are 
exposed add enough 1X high pH retrieval buffer to cover them again. 
19. Cook slides again in microwave at medium heat for 10 min. 
20. Let slides cool for 30 min. at RT. 
21. Wash slides 3 times with 1X PBS. 
22. Add M.O.M. blocking reagent in 1X PBS and incubate for 30 min. at RT. 
23. Replace blocking reagent with blocking buffer and primary antibody mix with 
antibodies against Ki67, Erg and Prox1 (Supplementary Table 2). 
Pause point: Incubate the slides O/N at 4°C. 
Day 5: Primary antibody washing, secondary antibody immunostaining, 
secondary antibody washing and mounting. Timing: 3h 
24. Wash slides 4 times with PBS+0.3% Triton-X100. 
25. Incubate slides with secondary antibody mix for 1 hour at RT. 
26. Wash slides 7 times with PBS+0.3% Triton-X100. 
27. Rinse slides once with 1X PBS. 
28. Dry slides and mount coverslips with ProLong Gold antifade reagent with 
DAPI. 
29. Place in slide storage box at 4°C 
Pause point: If samples are kept at 4°C and mounting medium remains, slides can 
be kept for up to a year. 
Day 6: Confocal microscopy. Timing: 6-8h 
30. Image stained paraffin sections from step 29 using the 405, 488, 543, and 647 
lasers (Supplementary Table 2) with the 40X objective of a confocal 
microscope, to analyze DAPI, Ki67, Prox1 and Erg, so that several villi can be 
imaged at once. Set pseudocolors as follows: white, DAPI; green, Ki67; red, 
Prox1; blue, Erg. Take images from 10-15 different regions in each sample. 
Day 7: Image analysis. Timing: 6-8h 
31. Import images from step 52 into FIJI. Open Cell Counter (Plugins> 
Analyze>Cell Counter).  
32. Turn off the DAPI channel (white). When counting proliferating blood and 
lymphatic endothelial cells switch off Prox1 (red) and Erg (blue), respectively, 
to avoid confusion. Once a Ki67+Erg+ is observed, switch back on Prox1 to 
verify if the cell is a lymphatic endothelial cell. Count cells according to 
Supplementary Table 3 using Cell Counter. 
33. Copy and paste results into a spreadsheet for analysis. 
 
TROUBLESHOOTING 
Troubleshooting advice is provided in Supplementary Table 4. 
 
TIMING 
Day 1: Steps 1-3, tissue dissection, preparation and fixation: 6-8h 
Day 2-3: Steps 4-7, sample washing and paraffin embedding: 2-3h 
Day 4: Steps 8-23, primary antibody immunostaining: 3h 
Day 5: Steps 24-29, primary antibody washing and secondary antibody 
immunostaining, secondary antibody washing and mounting: 3h 
Day 6: Step 30, confocal microscopy: 6-8h 
Day 7: Steps 31-33, image analysis: 6-8h 
   
Supplementary Table 1: Antibodies tested for whole-mount and paraffin section 
immunostaining. 
 Antibody 
Dilution 
(final conc.) Supplier 
Catalog 
number 
Clonality/ 
clone name 
WM/EP(-) 
needed? 
Wholemount 
α-SMA-Cy3 
(mouse) 
1:1000 
(1μg/ml) Sigma C6198 
monoclonal/ 
1A4 no 
β-catenin 
(rabbit) 
1:200 (from 
original stock) Millipore 06-734 Polyclonal yes (for stroma) 
CD3 
(armenian 
hamster) 
1:1000 
(0.5μg/ml) Biolegend 100301 
monoclonal/ 
145-2C11 no 
CD11b (rat) 1:200 
(1μg/ml) Biolegend 101201 
monoclonal/ 
M1-70 no 
Dll4 (goat) 1:300 
(0.66μg/ml) R&D AF1389 Polyclonal yes (for stroma) 
Endomucin 
(rat) 
1:250 (from 
original stock) eBioscience 14-5851-82 
monoclonal/ 
V.7C7 yes 
Erg (rabbit) 1:300 (from original stock) Abcam ab92513 
monoclonal/ 
EPR3864 no 
F4/80 (rat) 1:200 (from original stock) Invitrogen MF48000 
monoclonal/ 
BM8 no 
Fibronectin 
(rabbit) 
1:200 
(5μg/ml) Millipore AB2033 Polyclonal yes 
Lyve-1 
(rabbit) 
1:400 
(2.5μg/ml) AngioBio  11-034 Polyclonal no 
Lyve-1 (rat) 1:100 
(5μg/ml) R&D MAB2125 
monoclonal/ 
223322 no 
NG2 (rabbit) 1:1000 
(1μg/ml) Millipore AB5320 Polyclonal yes 
Pecam-1 (rat) 1:400 
(1.25μg/ml) 
BD 
Pharmingen 557355 
monoclonal/ 
MEC 13.3 no 
Periostin 
(goat) 
1:1000 
(0.2μg/ml) R&D AF2955 Polyclonal yes 
Pgp9.5 
(rabbit) 
1:1000 (from 
original stock) Abcam ab10404 Polyclonal no 
Tenascin C 
(rat) 
1:1000 
(0.5μg/ml) R&D MAB 2138 
monoclonal/ 
578 yes 
Vegfr-2 (goat) 1:100 
(2μg/ml) R&D AF644 Polyclonal no 
Vegfr-3 (goat) 1:100 
(2μg/ml) R&D MAB3491 Polyclonal no 
Vimentin 
(chicken) 
1:500 (from 
original stock) Millipore AB5733 Polyclonal yes 
Paraffin 
Ki67 (mouse) 1:300 
(1.66μg/ml) 
BD 
Pharmingen 556003 
monoclonal/ 
B56  
Meca32 (rat) 1:300 
(0.1μg/ml) 
BD 
Pharmingen 550563 
monoclonal/ 
MECA32  
Prox1 (goat) 1:150 
(1.33μg/ml) R&D AF2727 Polyclonal  
Secondary Abs 
Alexa Fluor 
488 
1:500 (WM) 
1:300 
(paraffin) 
Invitrogen    
Alexa Fluor 
555 Invitrogen    
Alexa Fluor 
647 Invitrogen       
Supplementary Table 2: Paraffin immunostaining antibody mix 
Primary 
antibodies 
Dilution 
(final 
concentration) 
Secondary 
antibodies 
Dilution 
(final 
concentration) 
Ki67 1:300 
(1.66 μg/ml) 
donkey 
anti-
mouse 
Alexa 488 
1:300 
(6.6 µg/ml) 
 
Prox1 1:300 
(0.33 μg/ml) 
donkey 
anti-goat 
Alexa 555 
1:300 
(6.6 µg/ml) 
 
ERG 1:200 
(4 μg/ml) 
donkey 
anti-rabbit 
Alexa 647 
1:300 
(6.6 µg/ml) 
    
Supplementary Table 3: Blood and lymphatic endothelial cell proliferation analysis 
strategy 
Cell-type Ki67 status Color 
LEC Neg magenta 
LEC + white 
BEC Neg blue 
BEC + cyan 
Assumes pseudocolors as the following: green, Ki67; red, Prox1; blue, 
Erg. LEC, lymphatic endothelial cell; BEC, blood endothelial cell.    
Supplementary Table 4: Troubleshooting for Supplementary Method 1 
Step Problem Possible reason Solution 
3 
Intestinal pieces for 
paraffin embedding 
do not stick to 
Whatman paper 
Well-perfused 
intestine sticks 
less well to 
Whatman paper. 
Use insect pins to pin intestinal pieces 
to Whatman paper. 
30 
Immunostaining does 
not work on paraffin 
sections 
Incomplete 
deparaffinization. 
Transfer slides from the heated block to 
100% xylene solution as quickly as 
possible. Also, ensure that 100% 
xylene is clean and does not already 
contain paraffin wax (step 9).  
